Statera Biopharma, Inc. (STAB)
OTCMKTS: STAB · Delayed Price · USD
0.0006
0.00 (0.00%)
Aug 30, 2024, 9:30 AM EDT - Market closed
Statera Biopharma Employees
Statera Biopharma had 46 employees as of December 31, 2021. The number of employees increased by 27 or 142.11% compared to the previous year.
Employees
46
Change (1Y)
27
Growth (1Y)
142.11%
Revenue / Employee
$80,166
Profits / Employee
-$1,996,361
Market Cap
43.55K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 46 | 27 | 142.11% |
| Dec 31, 2020 | 19 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
STAB News
- 1 year ago - Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs - GlobeNewsWire
- 1 year ago - Statera Biopharma Announces Completion of Application Process to Uplist to the OTCQB(R) Venture Marketplace - Accesswire
- 2 years ago - Statera Biopharma Receives Positive Nasdaq Listing Determination - Accesswire
- 2 years ago - Statera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOF - Accesswire
- 2 years ago - Statera Biopharma Announces Signing of a Binding MOU with Holobeam Technologies to Gain Access to Holobeam's Disruptive Diagnostic Imaging and Therapeutic Technology for Cancer Patients - Accesswire
- 2 years ago - Statera Biopharma Completes Fiscal 2021 Audit; Files Form 10-K - Accesswire
- 2 years ago - Statera Biopharma Receives Nasdaq Listing Determination; Hearing Requested to Address Filing Delinquency - Accesswire
- 2 years ago - Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq - Accesswire